Literature DB >> 11720320

Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity.

F T Veloso1, J T Ferreira, L Barros, S Almeida.   

Abstract

The aim of this study was to describe the clinical course of Crohn's disease (CD) in a well-defined, homogeneous groups of patients. A total of 480 patients with CD were followed up from diagnosis up to 20 years. Definitions of patient subgroups were made according to the Vienna Classification. Markov chain analysis was used to estimate the probabilities of remissions and relapses during the disease course. Both age at diagnosis and behavior were associated with different disease locations. Patients with ileal disease had a greater need for surgical and a lesser need for immunosuppressive treatment; patients with ileocolonic disease were diagnosed at an earlier age and showed a lower probability of remaining in remission during the disease course; patients with colonic disease needed less surgical or steroid treatments; patients with intestinal penetrating disease were frequently submitted to abdominal surgery, whereas those with anal-penetrating disease often needed immunosuppressive treatment. Approximately 40% of the patients were in clinical remission at any time, but only about 10% maintained a long-term remission free of steroids after their initial presentation. A more benign clinical course could be predicted in patients who stay in remission in the year after diagnosis. The grouping of patients with CD according to the Vienna Classification and/or the clinical activity in the year after diagnosis is useful in predicting the subsequent course of disease.

Entities:  

Mesh:

Year:  2001        PMID: 11720320     DOI: 10.1097/00054725-200111000-00005

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  29 in total

Review 1.  Management of Crohn's disease in smokers: is an alternative approach necessary?

Authors:  Pilar Nos; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

2.  Outcome of patients with nonstenotic, nonfistulizing Crohn's disease.

Authors:  Pilar Nos; Vicente Garrigues; Guillermo Bastida; Nuria Maroto; Marta Ponce; Julio Ponce
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 3.  The role of smoking in Crohn's disease as defined by clinical variables.

Authors:  Suhal S Mahid; Kyle S Minor; Patrick L Stevens; Susan Galandiuk
Journal:  Dig Dis Sci       Date:  2007-03-31       Impact factor: 3.199

4.  Evaluation of "top-down" treatment of early Crohn's disease by double balloon enteroscopy.

Authors:  Rong Fan; Jie Zhong; Zheng-Ting Wang; Shu-Yi Li; Jie Zhou; Yong-Hua Tang
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 5.  Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?

Authors:  Fernando Tavarela Veloso
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

6.  Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors.

Authors:  Aisaku Osamura; Yasuo Suzuki
Journal:  Dig Dis Sci       Date:  2017-12-05       Impact factor: 3.199

Review 7.  Clinical, serological and genetic predictors of inflammatory bowel disease course.

Authors:  Laurent Beaugerie; Harry Sokol
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 8.  Hematopoietic cell transplantation for Crohn's disease; is it time?

Authors:  Y Leung; M Geddes; J Storek; R Panaccione; P L Beck
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

9.  Disease behavior in children with Crohn's disease: the effect of disease duration, ethnicity, genotype, and phenotype.

Authors:  Ron Shaoul; Amir Karban; Shimon Reif; Batia Weiss; Raanan Shamir; Ada Tamir; Ofir Davidovich; Jonathan Halevi; Esther Leshinsky Silver; Arie Levine
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

10.  Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes.

Authors:  Sasha Taleban; Kathleen O Stewart; Darrick K Li; Prashant Singh; Darrell S Pardi; Holly C Sturgeon; Vijay Yajnik; Ramnik J Xavier; Ashwin N Ananthakrishnan; Hamed Khalili
Journal:  Dig Dis Sci       Date:  2016-05-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.